magnevist
bayer new zealand limited - meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) - solution for injection - 469 mg/ml - active: meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) excipient: meglumine pentetic acid water for injection
magnevist 0.5mmol/ml solution for injection 10ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 10ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 15ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 15ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 20ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 20ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 5ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist
bayer australia ltd - dimeglumine gadopentetate -
magnevist injection 469 mgml
bayer (south east asia) pte ltd - gadopentetic acid, dimeglumine salt - injection - 469 mg/ml - gadopentetic acid, dimeglumine salt 469 mg/ml